Dalva-Aydemir, S. Et Al. 2019. Toward <i>In Vitro</i> Epigenetic Drug Design for Thyroid Cancer: The Promise of PF-03814735, an Aurora Kinase Inhibitor.. Omics : a journal of integrative biology , vol.23 , 486-495.

Dalva-Aydemir, S., Akyerli, C., Yuksel, Ş., Keskin, H., & YAKICIER, M. C. , (2019). Toward <i>In Vitro</i> Epigenetic Drug Design for Thyroid Cancer: The Promise of PF-03814735, an Aurora Kinase Inhibitor.. Omics : a journal of integrative biology , vol.23, 486-495.

Dalva-Aydemir, Sevim Et Al. "Toward <i>In Vitro</i> Epigenetic Drug Design for Thyroid Cancer: The Promise of PF-03814735, an Aurora Kinase Inhibitor.," Omics : a journal of integrative biology , vol.23, 486-495, 2019

Dalva-Aydemir, Sevim Et Al. "Toward <i>In Vitro</i> Epigenetic Drug Design for Thyroid Cancer: The Promise of PF-03814735, an Aurora Kinase Inhibitor.." Omics : a journal of integrative biology , vol.23, pp.486-495, 2019

Dalva-Aydemir, S. Et Al. (2019) . "Toward <i>In Vitro</i> Epigenetic Drug Design for Thyroid Cancer: The Promise of PF-03814735, an Aurora Kinase Inhibitor.." Omics : a journal of integrative biology , vol.23, pp.486-495.

@article{article, author={Sevim Dalva-Aydemir Et Al. }, title={Toward <i>In Vitro</i> Epigenetic Drug Design for Thyroid Cancer: The Promise of PF-03814735, an Aurora Kinase Inhibitor.}, journal={Omics : a journal of integrative biology}, year=2019, pages={486-495} }